Company profile

BIOVALLEY company profile

Biovalley manufactures and sells the breviscapine series of drugs. They provide injections, capsules, tablets, dripping pills, erigeron capsules, and soft capsules. They provide solutions for ischemic cardiovascular and cerebrovascular diseases, stroke sequelae, and coronary heart disease treatment.

Business identity

Phone number
0871-65016111
Operating status
Active
Company type
For Profit
Employee range
00251-00500 employees
Founded
1999-06-13

Headquarters

Headquarters
Kunming, Yunnan, China
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
1
Total equity funding
$22.3M
Last funding
Post Ipo Equity / $22.3M / 2016-10-12
Last equity funding
Post Ipo Equity / $22.3M
Investors
1
Articles
1
Exited on
2015-08-11

Founders and investors

Investors

ShenZhen GTJA Investment Group

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.